Nipro (NPRRF) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NPRRF Nipro Corp NPRRF
74 GF Score
Price $9.96
GF Value $10.26
! 6 Warning Signs
View Full Analysis

What is Nipro Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nipro  (OTCPK:NPRRF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Nipro Cyclically Adjusted PS Ratio Related Terms


Nipro Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Nipro's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro Cyclically Adjusted PS Ratio Chart

Nipro Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.38 0.37 0.34 0.40

Nipro Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.34 0.33 0.40 0.40

NPRRF vs ISRG, BDX, RMD: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Nipro's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nipro's Cyclically Adjusted PS Ratio falls into.


NPRRF
74GF Score
Nipro Corp NPRRF
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nipro Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Nipro's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Nipro's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.798/113.6000*113.6000
=5.798

Current CPI (Jun. 2026) = 113.6000.

Nipro Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 4.634 98.000 5.372
201612 4.568 98.400 5.274
201703 4.744 98.100 5.494
201706 4.593 98.500 5.297
201709 4.635 98.800 5.329
201712 5.119 99.400 5.850
201803 5.634 99.200 6.452
201806 5.153 99.200 5.901
201809 5.168 99.900 5.877
201812 5.575 99.700 6.352
201903 5.313 99.700 6.054
201906 5.540 99.800 6.306
201909 5.837 100.100 6.624
201912 5.822 100.500 6.581
202003 5.952 100.300 6.741
202006 5.621 99.900 6.392
202009 5.924 99.900 6.736
202012 6.311 99.300 7.220
202103 6.615 99.900 7.522
202106 6.612 99.500 7.549
202109 6.877 100.100 7.804
202112 6.026 100.100 6.839
202203 5.646 101.100 6.344
202206 5.361 101.800 5.982
202209 5.203 103.100 5.733
202212 5.605 104.100 6.117
202303 6.432 104.400 6.999
202306 5.559 105.200 6.003
202309 5.459 106.200 5.839
202312 5.629 106.800 5.987
202403 6.097 107.200 6.461
202406 5.317 108.200 5.582
202409 6.558 108.900 6.841
202412 5.964 110.700 6.120
202503 6.650 111.100 6.800
202506 5.983 111.700 6.085
202509 5.828 112.000 5.911
202512 5.992 113.000 6.024
202603 6.770 112.700 6.824
202606 5.798 113.600 5.798

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Nipro (NPRRF) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be undervalued. The current stock price of $9.96 is trading 2.9% below its estimated GF Value™ of $10.26.

Key valuation signals for NPRRF:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $10.26 vs. price of $9.96 (2.9% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the NPRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nipro Business Description

Other Exchanges 8086:Japan5FA:Germany
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
74GF Score

Get the complete analysis for NPRRF

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.96
Price
$10.26
GF Value